Roshan Chikarmane. Ph.D. Student JHU On March 5, six days before the WHO officially recognized COVID-19 as a global pandemic1, the United States recorded 174 total confirmed cases within its…
Read More
Authors: Muzzammil Ahmadzada1, Waqas Haque2, and Muhammad A Saeed3 Affiliations: 1Johns Hopkins University; 2University of Texas Southwestern Medical School; 3 Zanvyl Krieger School of Arts and Sciences, Johns Hopkins University …
Authors: Muzzammil Ahmadzada1 and Waqas Haque2, MPH, MPHil Affiliations: 1Johns Hopkins University; 2University of Texas Southwestern Medical School Disclosures: The authors have no financial conflicts of interest. Ganaxolone is…
by Tawny Hammett, M.S. JHU Alumna The COVID-19 pandemic has transcended a mere influenza-like disease, showcasing a range of severity from mild cold symptoms to multi-organ failure and death1. Given…
by Yazmin I. Rovira Gonzalez, Ph.D., JHU Alumna CRISPR-Cas9 technology is a powerful tool for editing genomes, as it allows researchers to alter DNA sequences and modify gene function. It…
W. Taylor Cottle, PhD Candidate, HBN President The Hopkins Biotech Network continues to work towards building its network with industry and local leaders in the Baltimore Biotech and Pharma space….
Roshan Chikarmane, Co-Director of Alumni Relations, Ph.D. Candidate at Johns Hopkins School of Medicine Curious about career opportunities for life science students in pharmaceuticals, biotechnology, consulting, venture capital, and other…
John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone infected with cowpox to inoculate…
Tawny Hammett, M.S. Individualized Genomics & Health Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of tenuous recovery, bringing a welcomed…
Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger RNA-based vaccines and therapies –…
